To include your compound in the COVID-19 Resource Center, submit it here.

SERPINB1 and CXCR6 inhibition for multiple sclerosis

DISEASE CATEGORY: Autoimmune disease

INDICATION: Multiple sclerosis (MS)

Blocking the leukocyte esterase inhibitor SERPINB1 or the chemokine

Read the full 157 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE